Dolby Laboratories, Inc. Stock

Equities

DLB

US25659T1079

Software

Real-time Estimate Cboe BZX 03:22:41 2024-05-23 pm EDT 5-day change 1st Jan Change
80.02 USD -1.36% Intraday chart for Dolby Laboratories, Inc. -4.45% -7.29%
Sales 2024 * 1.29B Sales 2025 * 1.36B Capitalization 7.78B
Net income 2024 * 235M Net income 2025 * 270M EV / Sales 2024 * 6.01 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 5.71 x
P/E ratio 2024 *
32 x
P/E ratio 2025 *
28.8 x
Employees 2,246
Yield 2024 *
1.48%
Yield 2025 *
1.48%
Free-Float 61.43%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Dolby Laboratories, Inc. Presents at The 52nd J.P. Morgan Annual Global Technology, Media & Communications Conference, May-21-2024 03:45 PM
Dolby Laboratories Fiscal Q2 Adjusted Earnings Rise, Revenue Declines; Issues Fiscal Q3 Outlook MT
Transcript : Dolby Laboratories, Inc., Q2 2024 Earnings Call, May 02, 2024
Earnings Flash (DLB) DOLBY LABORATORIES Reports Q2 Revenue $364.5M, vs. Street Est of $359.4M MT
Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024 CI
Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on May 22, 2024 CI
Dolby Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 29, 2024 CI
Dolby Labs to Seek M&A CI
Transcript : Dolby Laboratories, Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-05-2024 08:45 AM
Dolby Laboratories, Inc. Announces Committee Changes CI
Tranche Update on Dolby Laboratories, Inc.'s Equity Buyback Plan announced on November 3, 2009. CI
Dolby Laboratories Fiscal Q1 Non-GAAP Net Income, Revenue Fall; Issues Q2 Guidance MT
Transcript : Dolby Laboratories, Inc., Q1 2024 Earnings Call, Feb 01, 2024
Dolby Laboratories, Inc. Reports Earnings Results for the First Quarter Ended December 29, 2023 CI
Dolby Laboratories, Inc. Announces A Cash Dividend on Class A and Class B Common Stock, Payable on February 22, 2024 CI
More news
1 day-0.11%
1 week-3.24%
Current month+4.18%
1 month+2.21%
3 months+1.15%
6 months-6.42%
Current year-6.12%
More quotes
1 week
80.54
Extreme 80.54
84.17
1 month
77.48
Extreme 77.48
85.30
Current year
77.48
Extreme 77.48
86.37
1 year
75.87
Extreme 75.87
91.02
3 years
61.55
Extreme 61.55
104.25
5 years
44.68
Extreme 44.68
104.74
10 years
29.87
Extreme 29.87
104.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 05-10-23
Director of Finance/CFO 54 21-10-14
Chief Tech/Sci/R&D Officer - 20-12-31
Members of the board TitleAgeSince
Chief Executive Officer 58 05-10-23
Chairman 65 03-05-31
Director/Board Member 63 09-02-23
More insiders
Date Price Change Volume
24-05-23 79.88 -1.54% 123 268
24-05-22 81.13 -0.61% 417,254
24-05-21 81.63 -1.28% 454,864
24-05-20 82.69 -1.38% 367,930
24-05-17 83.85 +0.28% 404,317

Delayed Quote Nyse, May 23, 2024 at 11:30 am EDT

More quotes
Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The Company's products are used in content creation, distribution and playback to enhance image and sound quality and improve transmission and playback. Its cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. The Company's other products include three dimensional glasses and kits, broadcast hardware and software. Its technology includes Dolby Atmos, Dolby TrueHD, Dolby Vision and Dolby Digital Plus.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
81.13 USD
Average target price
98 USD
Spread / Average Target
+20.79%
Consensus